National Utilization, Survival, and Costs Analysis of Treatment Options for Stage I Non-Small Cell Lung Cancer: A SEER-Medicare Database Analysis-Reference-Cited by-同舟云学术

National Utilization, Survival, and Costs Analysis of Treatment Options for Stage I Non-Small Cell Lung Cancer: A SEER-Medicare Database Analysis

Published:2021-08 Issue: Volume: Page:
ISSN:1076-6332
Container-title:Academic Radiology
language:en
Short-container-title:Academic Radiology

Author:

Mukherjee Kumar,Davisson Neena,Malik Sana,Duszak Richard,Kokabi Nima

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging

Reference22 articles.

1. SEER Cancer Stat Facts: Lung and Bronchus Cancer. National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/statfacts/html/lungb.html. Accessed at: 11/2020.

2. Survival rates after thermal ablation versus stereotactic radiation therapy for stage 1 non–small cell lung cancer: a national cancer database study;Johannes;Radiology,2018

3. An economic analysis of sublobar resection versus thermal ablation for early-stage non–small-cell lung cancer;Kwan;J Vasc Interv Radiol,2014

4. Stereotactic body radiation therapy for early-stage non-small cell lung cancer: executive summary of an ASTRO evidence-based guideline;Videtic;Pract Radiat Oncol,2017

5. Changes in treatment patterns and overall survival in patients with early-stage non–small cell lung cancer in the united states after the incorporation of stereotactic ablative radiation therapy;Haque;Am J Clin Oncol,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Racial disparity and regional variance in healthcare utilization among patients with lung cancer in US hospitals during 2016–2019;Archives of Public Health;2023-08-17

2. Stereotactic body radiation therapy and thermal ablation for treatment of NSCLC: A systematic literature review and meta-analysis;Lung Cancer;2023-08